Financial reports
10-Q
2022 Q2
Quarterly report
12 Aug 22
10-Q
2022 Q1
Quarterly report
20 May 22
NT 10-Q
Notice of late quarterly filing
16 May 22
10-K
2021 FY
Annual report
29 Mar 22
10-Q
2021 Q3
Quarterly report
17 Nov 21
NT 10-Q
Notice of late quarterly filing
16 Nov 21
10-Q
2021 Q2
Quarterly report
24 Aug 21
NT 10-Q
Notice of late quarterly filing
17 Aug 21
10-Q
2021 Q1
Quarterly report
8 Jun 21
NT 10-Q
Notice of late quarterly filing
18 May 21
Current reports
8-K
Other Events
26 Aug 22
8-K
Isleworth and Cytovia Terminate Merger Agreement
30 Jun 22
8-K
Regulation FD Disclosure
24 Jun 22
8-K
Entry into a Material Definitive Agreement
10 Jun 22
8-K
Cytovia Therapeutics Appoints Luca Scavo as Chief Financial Officer and James Priour as Chief Product Officer
7 Jun 22
8-K
Regulation FD Disclosure
6 Jun 22
8-K
Securities Purchase Agreement
10 May 22
8-K
Entry into a Material Definitive Agreement
26 Apr 22
8-K
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
26 Nov 21
8-K
Departure of Directors or Certain Officers
10 Sep 21
Registration and prospectus
15-12G
Securities registration termination
9 Sep 22
25-NSE
Exchange delisting
26 Aug 22
425
Business combination disclosure
24 Jun 22
425
Business combination disclosure
10 Jun 22
425
Business combination disclosure
10 Jun 22
425
Business combination disclosure
7 Jun 22
425
Business combination disclosure
6 Jun 22
425
Business combination disclosure
18 May 22
425
Business combination disclosure
10 May 22
425
Business combination disclosure
6 May 22
Ownership
SC 13G
GLAZER CAPITAL, LLC
14 Feb 22
3
Monica P Reed
10 Sep 21
4
MARC D KOZIN
10 Sep 21
SC 13D
Isleworth Healthcare Sponsor I LLC
12 Mar 21
4
ROBERT S WHITEHEAD
3 Mar 21
3
McKenna Michelle
24 Feb 21
3
Vipul Patel
24 Feb 21
3
DAN L HALVORSON
24 Feb 21
3
MARC D KOZIN
24 Feb 21
3
Allen R Weiss
24 Feb 21